MANNKIND CORP Nontrade Receivables, Current
MANNKIND CORP (MNKD) had Nontrade Receivables, Current of $803.00 thousand as of 2014-09-30, per its 10-Q filed 2014-11-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Receivables, Net, Current
us-gaap:NontradeReceivablesCurrent · last filed 2014-11-10
- 2014-09-30: Nontrade Receivables, Current $803.00K.
- 2013-09-30: Nontrade Receivables, Current $298.00K.
- 2013-06-30: Nontrade Receivables, Current $450.00K.
- 2013-03-31: Nontrade Receivables, Current $450.00K.
| Period end | Nontrade Receivables, Current |
|---|---|
| 2014-09-30 | $803.00K 10-Q · filed 2014-11-10 |
| 2013-09-30 | $298.00K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $450.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $450.00K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $450.00K 10-K · filed 2014-03-03 |
| 2011-12-31 | $0.00 10-K · filed 2012-03-15 |
| 2011-09-30 | $765.00K 10-Q · filed 2011-11-04 |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-04 |
| 2010-12-31 | $674.00K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |